Nodal activates smad and extracellular signal-regulated kinases 1/2 pathways promoting renal cell carcinoma proliferation

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 587-594

  Zhang, Zhiwei ^a   Jiang, Tao ^a   Li, Quanlin ^a   Wang, Jianbo ^a   Yang, Deyong ^a   Li, Xiancheng ^a   Wang, Qifei ^a   Song, Xishuang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Extracellular signal regulated kinases 1 2; Lefty; Nodal; Renal cell carcinoma; Smad

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; NODAL SIGNALING PROTEIN; SMAD PROTEIN; LEFT RIGHT DETERMINATION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NODAL PROTEIN, HUMAN; PROTEIN NODAL;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; WESTERN BLOTTING; AGED; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; TUMOR INVASION;

ADULT; AGED; APOPTOSIS; CARCINOMA, RENAL CELL; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEFT-RIGHT DETERMINATION FACTORS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NEOPLASM INVASIVENESS; NODAL PROTEIN;

EID: 84926615041     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3343     Document Type: Article

References (30)

1. Villa G and Hernández-Pastor LJ: Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain. BMC Cancer 13: 399, 2013.
2. Nguyen MM, Gill IS and Ellison LM: The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol 176: 2397-2400; discussion 2400, 2006.
3. Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM and Sadler GR: Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 179: 1704-1708, 2008.
4. Schier AF: Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol 19: 589-621, 2003.
5. Quail DF, Siegers GM, Jewer M and Postovit LM: Nodal signalling in embryogenesis and tumourigenesis. Int J Biochem Cell Biol 45: 885-898, 2013.
6. Tabibzadeh S and Hemmati-Brivanlou A: Lefty at the crossroads of 'stemness' and differentiative events. Stem Cells 24: 1998-2006, 2006.
7. Chen C and Shen MM: Two modes by which Lefty proteins inhibit nodal signaling. Curr Biol 14: 618-624, 2004.
8. Strizzi L, Hardy KM, Kirsammer GT, Gerami P and Hendrix MJ: Embryonic signaling in melanoma: potential for diagnosis and therapy. Lab Invest 91: 819-824, 2011.
9. Strizzi L, Postovit LM, Margaryan NV, et al: Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. Expert Rev Dermatol 4: 67-78, 2009.
10. Strizzi L, Hardy KM, Margaryan NV, et al: Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer. Breast Cancer Res 14: R75, 2012.
11. McAllister JC, Zhan Q, Weishaupt C, Hsu MY and Murphy GF: The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts. J Cutan Pathol 37 (Suppl 1): 19-25, 2010.
12. Postovit LM, Margaryan NV, Seftor EA and Hendrix MJ: Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell Melanoma Res 21: 348-357, 2008.
13. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM and Postovit LM: Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7: 246-255, 2007.
14. Postovit LM, Margaryan NV, Seftor EA, et al: Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 105: 4329-4334, 2008.
15. Cucina A, Biava PM, D'Anselmi F, et al: Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2). Apoptosis 11: 1617-1628, 2006.
16. Lee LM, Seftor EA, Bonde G, Cornell RA and Hendrix MJ: The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 233: 1560-1570, 2005.
17. Ebele JN, Sauter G, Epstein JI and Sesterhenn IA (eds): Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. 1st edition. International Agency for Research on Cancer Publications Collection, Lyon, 2004.
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds): AJCC Cancer Staging Manual. 7th edition. Springer, New York, NY, 2010.
19. Nadeem L, Munir S, Fu G, et al: Nodal signals through activin receptor-like kinase 7 to inhibit trophoblast migration and invasion: implication in the pathogenesis of preeclampsia. Am J Pathol 178: 1177-1189, 2011.
20. Kobayashi T, Liu X, Wen FQ, et al: Smad3 mediates TGF-beta1-induced collagen gel contraction by human lung fibroblasts. Biochem Biophys Res Commun 339: 290-295, 2006.
21. Papageorgiou I, Nicholls PK, Wang F, et al: Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reprod Biol Endocrinol 7: 122, 2009.
22. Lonardo E, Hermann PC, Mueller MT, et al: Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 9: 433-446, 2011.
23. Lawrence MG, Margaryan NV, Loessner D, et al: Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate 71: 1198-1209, 2011.
24. Strizzi L, Postovit LM, Margaryan NV, et al: Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis 29: 91-103, 2008.
25. Cavallari C, Fonsato V, Herrera MB, Bruno S, Tetta C and Camussi G: Role of Lefty in the anti tumor activity of human adult liver stem cells. Oncogene 32: 819-826, 2013.
26. Saito A, Ochiai H, Okada S, Miyata N and Azuma T: Suppression of Lefty expression in induced pluripotent cancer cells. FASEB J 27: 2165-2174, 2013.
27. Topczewska JM, Postovit LM, Margaryan NV, et al: Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 12: 925-932, 2006.
28. Hardy KM, Kirschmann DA, Seftor EA, et al: Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res 70: 10340-10350, 2010.
29. Miyata N, Azuma T, Hozawa S, et al: Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty. Pancreas 41: 745-752, 2012.
30. De Silva T, Ye G, Liang YY, Fu G, Xu G and Peng C: Nodal promotes glioblastoma cell growth. Front Endocrinol (Lausanne) 3: 59, 2012.